CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$1.14
+11.76%Next report
Analyst consensus
- Next report date
- Dec 17, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- $5.8M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.07
- Revenue actual
- $1.5M
- Revenue estimate
- $2.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -666.1%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.07 | -$0.08 | Miss -14.29% | $1.5M |
| May 15, 2026 | -$0.01 | -$0.27 | Miss -2600.00% | $1.7M |
| Feb 13, 2026 | -$0.04 | -$0.06 | Miss -50.00% | $3.9M |
| Dec 23, 2025 | -$0.06 | -$0.06 | In line | — |
| Aug 12, 2025 | -$0.15 | -$0.08 | Beat 46.67% | — |
| May 14, 2025 | -$0.09 | -$0.11 | Miss -22.22% | — |
| Feb 14, 2025 | -$0.06 | -$0.09 | Miss -50.00% | — |
| Dec 27, 2024 | -$0.08 | -$0.07 | Beat 10.33% | — |
| Mar 31, 2024 | — | $0.01 | — | — |
| Dec 31, 2023 | — | -$0.05 | — | — |
| Sep 30, 2023 | — | $0.00 | — | — |
| Jun 30, 2023 | — | $0.07 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 17, 2026